{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T21:45:47Z","timestamp":1788039947143,"version":"build-2784847793"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T00:00:00Z","timestamp":1685059200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001171","name":"Cancer Institute NSW","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001102","name":"Cancer Council NSW","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001102","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>\u201cMainstreaming\u201d is a proposed strategy to integrate genomic testing into oncology. The aim of this paper is to develop a mainstreaming oncogenomics model by identifying health system interventions and implementation strategies for mainstreaming Lynch syndrome genomic testing.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A rigorous theoretical approach inclusive of conducting a systematic review and qualitative and quantitative studies was undertaken using the Consolidated Framework for Implementation Research. Theory-informed implementation data were mapped to the Genomic Medicine Integrative Research framework to generate potential strategies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The systematic review identified a lack of theory-guided health system interventions and evaluation for Lynch syndrome and other mainstreaming programs. The qualitative study phase included 22 participants from 12 health organizations. The quantitative Lynch syndrome survey included 198 responses: 26% and 66% from genetic and oncology health professionals, respectively. Studies identified the relative advantage and clinical utility of mainstreaming to improve genetic test access and to streamline care, and adaptation of current processes was recognized for results delivery and follow-up. Barriers identified included funding, infrastructure and resources, and the need for process and role delineation. The interventions to overcome barriers were as follows: embedded mainstream genetic counselors, electronic medical record genetic test ordering, results tracking, and mainstreaming education resources. Implementation evidence was connected through the Genomic Medicine Integrative Research framework resulting in a mainstreaming oncogenomics model.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>The proposed mainstreaming oncogenomics model acts as a complex intervention. It features an adaptable suite of implementation strategies to inform Lynch syndrome and other hereditary cancer service delivery. Implementation and evaluation of the model are required in future research.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2023.1140135","type":"journal-article","created":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T18:18:50Z","timestamp":1685125130000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["A mainstreaming oncogenomics model: improving the identification of Lynch syndrome"],"prefix":"10.3389","volume":"13","author":[{"given":"Rosie","family":"O\u2019Shea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Crook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maira","family":"Kentwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Gleeson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine M.","family":"Tucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Hampel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alanna Kulchak","family":"Rahm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole M.","family":"Rankin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,5,26]]},"reference":[{"key":"B1","unstructured":"eviQ 2020 version 9 BRCA 1 and 2 genetic testing"},{"key":"B2","unstructured":"Clinical practice guidelines in oncology. Genetic\/Familial high risk assessment: breast, ovarian and pancreatic cancer. version 1.2020"},{"key":"B3","unstructured":"Familial breast cancer clinical guideline2019"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2015.04.029","article-title":"Adherence patterns to national comprehensive cancer network (NCCN) guidelines for referral to cancer genetic professionals","volume":"138","author":"Febbraro","year":"2015","journal-title":"Gyn Onc"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0b013e318280f2b4","article-title":"Does the diagnosis of breast or ovarian cancer trigger referral to genetic counseling","volume":"23","author":"Powell","year":"2013","journal-title":"Int J Gynecol Cancer"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2013.05.003","article-title":"Keeping it simple: genetics referrals for all invasive serous ovarian cancers","volume":"130","author":"Demsky","year":"2013","journal-title":"Gyn Onc"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2016.02.011","article-title":"Underuse of BRCA testing in patients with breast and ovarian cancer","volume":"214","author":"Wright","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"9625638","DOI":"10.1155\/2017\/9625638","article-title":"Recognition of lynch syndrome amongst newly diagnosed colorectal cancers at st. paul\u2019s hospital","volume":"2017","author":"Pi","year":"2017","journal-title":"Can J Gastroenterol Hepatol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2010.03.010","article-title":"Underdiagnoses of lynch syndrome involves more than family history criteria","volume":"8","author":"Singh","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2020.05.014","article-title":"Setting a baseline: a 7-year review of referral rates and outcomes for serous ovarian cancer prior to implementation of oncologist mediated genetic testing","volume":"158","author":"Armel","year":"2020","journal-title":"Gynae Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.39.8545","article-title":"BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian ovarian cancer study group","volume":"30","author":"Alsop","year":"2012","journal-title":"J Clin Onc"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.26576","article-title":"Prevalence of BRCA mutations in an unselected population of triple-negative breast cancer","volume":"118","author":"Hartman","year":"2012","journal-title":"Cancer"},{"key":"B13","unstructured":"Clinical practice guidelines in oncology. Genetic\/Familial high-risk assesment: colorectal, V 1.2020"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-319915","article-title":"Hereditary CRC guidelines eDelphi consensus group guidelines for the management of hereditary colorectal cancer from the British society of gastroenterology (BSG)\/Association of coloproctology of great Britain and Ireland (ACPGBI)\/ united kingdom cancer genetics group (UKCGG)","volume":"69","author":"Monahan","year":"2020","journal-title":"Gut"},{"key":"B15","unstructured":"AustraliaCancer Institute NSWMismatch repair (MMR) genetic testing2019"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/cge.12994","article-title":"Use of multigene-panel identifies pathogenic variants in several CRC-predisposing genes in patients previously tested for lynch syndrome","volume":"92","author":"Hansen","year":"2017","journal-title":"Clin Genet"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2016.5194","article-title":"Prevalence and spectrum of germline cancer susceptibility gene mutations among patients with early-onset colorectal cancer","volume":"3","author":"Pearlman","year":"2017","journal-title":"JAMA Oncol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2016.135","article-title":"Germline multi-gene hereditary cancer panel testing in an unselected endometrial cancer cohort","volume":"29","author":"Ring","year":"2016","journal-title":"Mod Pathol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13053-016-0048-3","article-title":"Intensive breast screening in BRCA2 mutation carriers is associated with reduced breast cancer specific and all cause mortality","volume":"14","author":"Evans","year":"2016","journal-title":"Hered Cancer Clin Pract"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.1237","article-title":"Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality","volume":"304","author":"Domchek","year":"2010","journal-title":"JAMA"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1186\/s12905-014-0150-5","article-title":"Risk-reducing salpingooophorectomy: a meta-analysis on impact on ovarian cancer risk and all cause mortality in BRCA 1 and BRCA 2 mutation carriers","volume":"14","author":"Marchetti","year":"2014","journal-title":"BMC Womens Health"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.02.053","article-title":"One to 2-year surveillance intervals reduce risk of colorectal cancer in families with lynch syndrome","volume":"138","author":"Vasen","year":"2010","journal-title":"Gastroenterology"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1136\/bmj.38606.794560","article-title":"Prevention of colorectal cancer by colonoscopic surveillance in individuals with a family history of colorectal cancer: 16 year, prospective, follow up study","volume":"331","author":"Dove-Edwin","year":"2005","journal-title":"BMJ"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1158\/1940-6207.CAPR-20-0002","article-title":"Population-based genetic testing for precision prevention (2020)","volume":"13","author":"Evans","year":"2020","journal-title":"Cancer Prev Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1159\/000352028","article-title":"Population-based, risk-stratified genetic testing for ovarian cancer risk: a focus group study","volume":"16","author":"Meisel","year":"2013","journal-title":"Public Health Genomics"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/ejhg.2015.117","article-title":"Preferences for genetic testing for colorectal cancer within a population-based screening program: a discrete choice experiment","volume":"24","author":"Veldwijk","year":"2016","journal-title":"Eur J Hum Genet"},{"key":"B27","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12905-016-0325-3","article-title":"Genetic testing and personalized ovarian cancer screening: a survey of public attitudes","volume":"16","author":"Meisel","year":"2016","journal-title":"BMC Womens Health"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-017675","article-title":"Anticipated health behaviour changes and perceived control in response to disclosure of genetic risk of breast and ovarian cancer: a quantitative survey study among women in the UK","volume":"7","author":"Meisel","year":"2017","journal-title":"BMJ Open"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/ejhg.2013.36","article-title":"Eliciting preferences for priority setting in genetic testing: a pilot study comparing best-worst scaling and discrete choice experiments","volume":"21","author":"Severin","year":"2013","journal-title":"Eur J Hum Genet"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jgc4.1305","article-title":"Genetic counselors\u2019 perspectives on population-based screening for BRCA-related hereditary breast and ovarian cancer and lynch syndrome","author":"De Simone","year":"2020","journal-title":"J Genet Couns"},{"key":"B31","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12905-017-0488-6","article-title":"Health care professionals\u2019 attitudes towards population-based genetic testing and riskstratification for ovarian cancer: a crosssectional survey","volume":"17","author":"Hann","year":"2017","journal-title":"BMC Women's Health"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-143-5-200509060-00011","article-title":"Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement","volume":"143","year":"2005","journal-title":"Ann Intern Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.7326\/M13-2747","article-title":"Risk assessment,genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. preventive services task force recommendation statement","volume":"160","author":"Moyer","year":"2014","journal-title":"Ann Intern Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/GIM.0b013e31818fa2ff","article-title":"Recommendations from the EGAPP working group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from lynch syndrome in relatives","volume":"11","year":"2009","journal-title":"Genet Med"},{"key":"B35","unstructured":"CDC Science making a difference\u2013five domains of influence"},{"key":"B36","volume-title":"The learning healthcare system: workshop summary","author":"Olsen","year":"2007"},{"key":"B37","volume-title":"Genomics-enabled learning health care systems: gathering and using genomic information to improve patient care and research: workshop summary","year":"2015"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2017.144","article-title":"Developing a common framework for evaluating the implementation of genomic medicine interventions in clinical care: the IGNITE network\u2019s common measures working group","volume":"20","author":"Orlando","year":"2018","journal-title":"Genet Med"},{"key":"B39","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1748-5908-4-50","article-title":"Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science","volume":"4","author":"Damschroder","year":"2009","journal-title":"Implement Sci"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2019.04.006","article-title":"The genomic medicine integrative research framework: a conceptual framework for conducting genomic medicine research","volume":"104","author":"Horowitz","year":"2019","journal-title":"Am J Hum Genet"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0250379","article-title":"Health system interventions to integrate genetic testing in routine oncology services: a systematic review","volume":"16","author":"O\u2019Shea","year":"2021","journal-title":"PloS One"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/s41436-020-0838-x","article-title":"How can Australia integrate routine genetic sequencing in oncology: a qualitative study through an implementation science lens","volume":"22","author":"O\u2019Shea","year":"2020","journal-title":"Genet Med"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/s41431-021-00871-4","article-title":"Stakeholders\u2019 views of integrating universal tumour screening and genetic testing for colorectal and endometrial cancer into routine oncology","volume":"29","author":"O\u2019Shea","year":"2021","journal-title":"Eu J Hum Genet"},{"key":"B44","volume-title":"Designing and conducting mixed methods research","author":"Creswell","year":"2011"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1111\/1475-6773.12117","article-title":"Achieving integration in mixed methods designs: principles and practices","volume":"48","author":"Fetters","year":"2013","journal-title":"Health Serv Res"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1097\/00006199-199103000-00014","article-title":"Approaches to qualitative-quantitative methodological triangulation","volume":"40","author":"Morse","year":"1991","journal-title":"Nurs Res"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/s41436-020-0785-6","article-title":"Mainstreaming genetics and genomics: a systematic review of the barriers and facilitators for nurses and physicians in secondary and tertiary care","volume":"22","author":"White","year":"2020","journal-title":"Genet Med"},{"key":"B48","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1053\/j.seminoncol.2019.05.001","article-title":"Healthcare professionals\u2019 attitudes toward cancer precision medicine: a systematic review","volume":"46","author":"Vetsch","year":"2019","journal-title":"Semin Oncol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2017.01.030","article-title":"Mainstreaming cancer genetics: a model integrating germline BRCA testing into routine ovarian cancer clinics","volume":"145","author":"Kentwell","year":"2017","journal-title":"Gynecol Oncol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2017.07.141","article-title":"Genetic consultation embedded in a gynecologic oncology clinic improves compliance with guideline-based care","volume":"147","author":"Senter","year":"2017","journal-title":"Gynecol Oncol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"S0090","DOI":"10.1016\/j.ygyno.2020.11.003","article-title":"Embedding a genetic counselor into oncology clinics improves testing rates and timeliness for women with ovarian cancer","volume":"21","author":"Rana","year":"2020","journal-title":"Gynecol Oncol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3322\/caac.20119","article-title":"ProvenCare lung cancer: a multi-institutional improvement collaborative","volume":"61","author":"Katlic","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1038\/s41436-020-01056-y","article-title":"Real-world integration of genomic data into the electronic health record: the PennChart genomics initiative","volume":"10","author":"Lau-Min","year":"2020","journal-title":"Genet Med"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1140135\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T18:18:58Z","timestamp":1685125138000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1140135\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,26]]},"references-count":53,"alternative-id":["10.3389\/fonc.2023.1140135"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2023.1140135","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,26]]},"article-number":"1140135"}}